These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7819002)

  • 1. Effect of cyclosporine A on long-term allograft function in pediatric renal transplant recipients.
    Williams AW; Morgenstern BZ; Murphy M; Milliner DS
    Pediatr Nephrol; 1994 Oct; 8(5):566-9. PubMed ID: 7819002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation.
    Hilbrands LB; Hoitsma AJ; Koene KA
    Transplantation; 1996 Apr; 61(7):1038-46. PubMed ID: 8623182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, prospective study on the conversion from cyclosporine-prednisone to cyclosporine-azathioprine at 6 months after renal transplantation.
    de Sévaux RG; Hilbrands LB; Tiggeler RG; Koene RA; Hoitsma AJ
    Transpl Int; 1998; 11 Suppl 1():S322-4. PubMed ID: 9665006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?
    Marcén R; Pascual J; Teruel JL; Villafruela JJ; Rivera ME; Mampaso F; Burgos FJ; Ortuño J
    Transplantation; 2001 Jul; 72(1):57-62. PubMed ID: 11468535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction.
    Pascual J; Marcén R; Orofino L; Quereda C; Mampaso F; Liaño F; Ortuño J
    Transplantation; 1991 Aug; 52(2):276-9. PubMed ID: 1871800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.
    MacPhee IA; Bradley JA; Briggs JD; Junor BJ; MacPherson SG; McMillan MA; Rodger RS; Watson MA
    Transplantation; 1998 Nov; 66(9):1186-92. PubMed ID: 9825816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols.
    Meier-Kriesche HU; Friedman G; Jacobs M; Mulgaonkar S; Vaghela M; Kaplan B
    Transplantation; 1999 Nov; 68(10):1496-502. PubMed ID: 10589946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients.
    Thomas DW; Baboolal K; Subramanian N; Newcombe RG
    J Clin Periodontol; 2001 Jul; 28(7):706-9. PubMed ID: 11422595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
    Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
    Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
    Gruber SA; Gillingham K; Sothern RB; Stephanian E; Matas AJ; Dunn DL
    Clin Transplant; 1994 Aug; 8(4):388-95. PubMed ID: 7949545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients.
    Hilbrands LB; Demacker PN; Hoitsma AJ; Stalenhoef AF; Koene RA
    J Am Soc Nephrol; 1995 Jun; 5(12):2073-81. PubMed ID: 7579056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
    Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Richards TM; Crotty PH; Beaver SJ; Steers JL; Wiesner RH
    Mayo Clin Proc; 1994 Feb; 69(2):105-11. PubMed ID: 7508536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.